RPS6 and prostate carcinoma: ✓IKAP-KD reduces p-RPS6 (S235/236) concurrently with an increase in cell growth in LNCaP prostate cancer cells [155]✓antagonizes AR-dependent proliferation in LNCaP cells via both mTORC1-dependent and mTORC1-independent pathways [155]